On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Diamyd Therapeutics AB's own share of each project, not the project's full budget.
- FP7 (2007 to 2013)€133k · 1 project
Projects
1 EU-funded project, newest first. Each links to the official record.
- PEVNETPartner
Persistent virus infection as a cause of pathogenic inflammation in type 1 diabetes - an innovative research program of biobanks and expertise
FP7 (2007 to 2013) · 2011–2016 · Project on CORDIS ↗
€133ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- The Chancellor Masters and Scholars of the University of CambridgeUnited Kingdom · 1 shared project
- Karolinska InstitutetSweden · 1 shared project
- Helsingin YliopistoFinland · 1 shared project
- Uppsala UniversitetSweden · 1 shared project
- Universitetet i OsloNorway · 1 shared project
- King'S College LondonUnited Kingdom · 1 shared project
- The University of ExeterUnited Kingdom · 1 shared project
- Turun YliopistoFinland · 1 shared project
- Linkopings UniversitetSweden · 1 shared project
- Universita Degli Studi di SienaItaly · 1 shared project
- Centre Hospitalier Regional et Universitaire de LilleFrance · 1 shared project
- Tampereen YliopistoFinland · 1 shared project
- Vactech OyFinland · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- diabetes
- vaccines
- virology
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗
